Sign in

CIK 0002007919 · <br>Emerging growth company

Inhibrx Biosciences, Inc.

Sign in to watch
Ticker
INBX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
990613523
Phone
(858) 795-4220
Business address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
  1. 4 Open-market buy Director bought 57,549 shares at an average $17.32 ($997,024)
  2. SC 13G Stake Amended Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Director bought 286,786 shares at an average $17.18 ($4,927,580)
  5. SC 13D Stake Beneficial Ownership Report
  6. SC 13D Stake Beneficial Ownership Report
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Other disposition 10% owner disposed of 13,316,140 shares (other)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Executive Officer acquired 761,413 shares (grant or award)
  12. 4 Grant or award Director acquired 818,575 shares (grant or award)
  13. 4 Grant or award Director acquired 149,564 shares (grant or award)
  14. 4 Grant or award Chief Scientific Officer acquired 513,888 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 7 of 8 · 158 filings